-
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
At ProteoGenix, we are devoted to promoting innovative research and offering superior solutions that assist our clients in reaching their scientific objectives. Our client at the University of Naples and…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Antibody production
Advances in Animal-Free Monoclonal Antibody Production
Read more -
Antibody production
Exploring Single B-Cell Technologies for Antibody Discovery
Read more -
Antibody production
Phage Display vs. Hybridoma: Choosing the Right Method for Monoclonal Antibody Production
Read more
-
Antibody-drug conjugates
Everything you need to know about the generation of antibody-drug conjugates (ADCs)
Read more -
CAR-T cell therapy
CAR-T cell engineering: strategies to overcome remaining limitations
Read more -
Antibody production
Fundamental and advanced methods to improve monoclonal antibody production in vitro
Read more -
Antibody production
The untapped potential of bispecific antibody therapies
Read more -
Antibody production
What are the leading monoclonal antibody treatments for cancer?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more